Access all publications from Mapi Research Trust in various field: PROQOLID COA database, COA copyright, linguistic validation, Oncology, rare diseases, etc. http://mapi-trust.org/resources/publications/
Read our whitepapers and get insights for optimized selection and implementation of COAs and eCOA in clinical trials. http://mapi-trust.org/resources/whitepapers/
Access a list of learned societies and Health Authorities in relation to the use of Clinical Outcome Assessments in clinical trials. http://mapi-trust.org/resources/useful-links/
Watch all Mapi Research Trust webinar recordings on challenges and solutions in the field of Clinical Outcome Assessments (COA and eCOA). http://mapi-trust.org/resources/webinars/
Resilience as a protective factor on the quality of life (QoL) of Indian nursing students during the COVID-19 pandemic
The COVID-19 pandemic negatively impacted the quality of life of individuals around the world, including health care professionals. There has been little research that examines the role of resilience concerning the impact of COVID-19 on the quality of ...
MGC Pharmaceuticals advances phase 3 clinical trial of CimetrA for the treatment of COVID-19
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) is currently undertaking a phase 3 clinical trial of CimetrA in Israel as an investigational medicinal...
Overwatch 2 is a free-to-play, team-based action game set in the optimistic future, where every match is the ultimate 5v5 battlefield brawl. Play as a time-jumping freedom fighter, a beat-dropping battlefield DJ, or one of over 30 other unique heroes as you battle it out around the globe.
MGC Pharmaceuticals "totally understands" CimetrA after MoA study
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief medical officer Nadya Lisovoder speaks to Proactive's Thomas Warner after announcing the completion of an in-vitro pre-clinical mechanism...
MGC Pharmaceuticals Says Preclinical Trial Results for Cimetra Show Drug Is Safe
By Joe Hoppe MGC Pharmaceuticals said results from a preclinical toxicology trial of its anti-inflammatory drug Cimetra were positive, finding the drug to be...
Moderate to severe plaque psoriasis | CIMZIA® (certolizumab pegol)
CIMZIA® (certolizumab pegol) offers rapid skin improvement that lasts for patients with plaque psoriasis, regardless of prior biologic treatment, who are candidates for systemic therapy or phototherapy.
Prostaglandin API | Dinoprost tromethamine API | Epoprostenol Sodium API
Pfizer CentreOne are manufacturers of the Prostaglandin APIs: Dinoprost Tromethamine & Epoprostenol Sodium for pharmaceutical and agriculture applications.
Partial COVID-19 COA listing - Mapi Research Trust
Mapi Research Trust is a non-profit organization dedicated to improving patients’ quality of life by facilitating access to Patient-Centered Outcome (PCO) information http://mapi-trust.org/questionnaires/covid-19-questionnaires/partial-covid-19-coa-list/